Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

Designing a wrist-worn sensor to improve medication adherence: accommodating diverse user behaviors and technology preferences.

Marquard JL, Saver B, Kandaswamy S, Martinez VI, Simoni JM, Stekler JD, Ganesan D, Scanlan J.

JAMIA Open. 2018 Oct;1(2):153-158. doi: 10.1093/jamiaopen/ooy035. Epub 2018 Aug 27.

2.

Predictors of Art and PrEP Adherence and Medication-Taking Practices and Preferences to Inform Development of a Wrist-Worn Adherence System.

Stekler JD, Scanlan JM, Simoni JM, Crane HM, Fredericksen RJ, Marquard J, Saver BG.

AIDS Educ Prev. 2018 Oct;30(5):357-368. doi: 10.1521/aeap.2018.30.5.357.

PMID:
30332308
3.

Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials.

Rosenstock J, Marquard J, Laffel LM, Neubacher D, Kaspers S, Cherney DZ, Zinman B, Skyler JS, George J, Soleymanlou N, Perkins BA.

Diabetes Care. 2018 Dec;41(12):2560-2569. doi: 10.2337/dc18-1749. Epub 2018 Oct 4.

PMID:
30287422
4.

Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth With Type 2 Diabetes.

Bjornstad P, Laffel L, Tamborlane WV, Simons G, Hantel S, von Eynatten M, George J, Marquard J, Cherney DZI.

Diabetes Care. 2018 Aug;41(8):e129-e130. doi: 10.2337/dc18-0394. Epub 2018 Jun 25. No abstract available.

PMID:
29941496
5.

Empagliflozin as adjunct to insulin in Japanese participants with type 1 diabetes: Results of a 4-week, double-blind, randomized, placebo-controlled phase 2 trial.

Shimada A, Hanafusa T, Yasui A, Lee G, Taneda Y, Sarashina A, Shiki K, George J, Soleymanlou N, Marquard J.

Diabetes Obes Metab. 2018 Sep;20(9):2190-2199. doi: 10.1111/dom.13351. Epub 2018 Jun 5.

6.

Pharmacokinetic and pharmacodynamic profile of the sodium-glucose co-transporter-2 inhibitor empagliflozin in young people with Type 2 diabetes: a randomized trial.

Laffel LMB, Tamborlane WV, Yver A, Simons G, Wu J, Nock V, Hobson D, Hughan KS, Kaspers S, Marquard J.

Diabet Med. 2018 Aug;35(8):1096-1104. doi: 10.1111/dme.13629. Epub 2018 May 6.

7.

The Stay S.A.F.E. Strategy for Managing Interruptions Reduces Distraction Time in the Simulated Clinical Setting.

Henneman EA, Marquard JL, Nicholas C, Martinez V, DeSotto K, Scott SS, Soares WE, Henneman PL.

Crit Care Nurs Q. 2018 Apr/Jun;41(2):215-223. doi: 10.1097/CNQ.0000000000000201.

PMID:
29494376
8.

Meaningful use's benefits and burdens for US family physicians.

Holman GT, Waldren SE, Beasley JW, Cohen DJ, Dardick LD, Fox CH, Marquard J, Mullins R, North CQ, Rafalski M, Rivera AJ, Wetterneck TB.

J Am Med Inform Assoc. 2018 Jun 1;25(6):694-701. doi: 10.1093/jamia/ocx158.

PMID:
29370425
9.

Usability Evaluation of an EHR's Clinical Notes Interface from the Perspective of Attending and Resident Physicians: An Exploratory Study.

Rizvi RF, Marquard JL, Seywerd MA, Adam TJ, Elison JT, Hultman GM, Harder KA, Melton GB.

Stud Health Technol Inform. 2017;245:1128-1132.

PMID:
29295278
10.

Population Pharmacokinetic- Pharmacodynamic Analysis to Characterize the Effect of Empagliflozin on Renal Glucose Threshold in Patients With Type 1 Diabetes Mellitus.

Mondick J, Riggs M, Kaspers S, Soleymanlou N, Marquard J, Nock V.

J Clin Pharmacol. 2018 May;58(5):640-649. doi: 10.1002/jcph.1051. Epub 2017 Dec 18.

PMID:
29251772
11.

Usability Evaluation of Electronic Health Record System around Clinical Notes Usage-An Ethnographic Study.

Rizvi RF, Marquard JL, Hultman GM, Adam TJ, Harder KA, Melton GB.

Appl Clin Inform. 2017 Oct;8(4):1095-1105. doi: 10.4338/ACI-2017-04-RA-0067. Epub 2017 Dec 14.

12.

Randomized, double-blind, placebo-controlled dose-finding study of the dipeptidyl peptidase-4 inhibitor linagliptin in pediatric patients with type 2 diabetes.

Tamborlane WV, Laffel LM, Weill J, Gordat M, Neubacher D, Retlich S, Hettema W, Hoesl CE, Kaspers S, Marquard J.

Pediatr Diabetes. 2018 Jun;19(4):640-648. doi: 10.1111/pedi.12616. Epub 2017 Nov 24.

PMID:
29171139
13.

Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review.

Fazeli Farsani S, Brodovicz K, Soleymanlou N, Marquard J, Wissinger E, Maiese BA.

BMJ Open. 2017 Aug 1;7(7):e016587. doi: 10.1136/bmjopen-2017-016587. Review. Erratum in: BMJ Open. 2017 Sep 1;7(8):e016587corr1.

14.

Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention.

Bausch B, Schiavi F, Ni Y, Welander J, Patocs A, Ngeow J, Wellner U, Malinoc A, Taschin E, Barbon G, Lanza V, Söderkvist P, Stenman A, Larsson C, Svahn F, Chen JL, Marquard J, Fraenkel M, Walter MA, Peczkowska M, Prejbisz A, Jarzab B, Hasse-Lazar K, Petersenn S, Moeller LC, Meyer A, Reisch N, Trupka A, Brase C, Galiano M, Preuss SF, Kwok P, Lendvai N, Berisha G, Makay Ö, Boedeker CC, Weryha G, Racz K, Januszewicz A, Walz MK, Gimm O, Opocher G, Eng C, Neumann HPH; European-American-Asian Pheochromocytoma-Paraganglioma Registry Study Group.

JAMA Oncol. 2017 Sep 1;3(9):1204-1212. doi: 10.1001/jamaoncol.2017.0223.

15.

Model Guided Design and Development Process for an Electronic Health Record Training Program.

He Z, Marquard J, Henneman E.

AMIA Annu Symp Proc. 2017 Feb 10;2016:1814-1821. eCollection 2016.

16.

Eye Tracking: A Novel Approach for Evaluating and Improving the Safety of Healthcare Processes in the Simulated Setting.

Henneman EA, Marquard JL, Fisher DL, Gawlinski A.

Simul Healthc. 2017 Feb;12(1):51-56. doi: 10.1097/SIH.0000000000000192.

PMID:
28146453
17.

Strategies for clinical implementation of screening for hereditary cancer syndromes.

Heald B, Marquard J, Funchain P.

Semin Oncol. 2016 Oct;43(5):609-614. doi: 10.1053/j.seminoncol.2016.08.008. Epub 2016 Sep 21. Review.

PMID:
27899194
18.

Assessing the effectiveness of five process elicitation methods: A case study of chemotherapy treatment plan review.

Christov SC, Marquard JL, Avrunin GS, Clarke LA.

Appl Ergon. 2017 Mar;59(Pt A):364-376. doi: 10.1016/j.apergo.2016.08.032. Epub 2016 Oct 11.

PMID:
27890149
19.

Usability Testing of Two Ambulatory EHR Navigators.

Hultman G, Marquard J, Arsoniadis E, Mink P, Rizvi R, Ramer T, Khairat S, Fickau K, Melton GB.

Appl Clin Inform. 2016 Jun 15;7(2):502-15. doi: 10.4338/ACI-2015-10-RA-0129. eCollection 2016.

20.

Assessment of clinical workload for general and specialty genetic counsellors at an academic medical center: a tool for evaluating genetic counselling practices.

Heald B, Rybicki L, Clements D, Marquard J, Mester J, Noss R, Nardini M, Polk J, Psensky B, Rigelsky C, Schreiber A, Shealy A, Smith M, Eng C.

NPJ Genom Med. 2016 May 11;1:16010. doi: 10.1038/npjgenmed.2016.10. eCollection 2016.

Supplemental Content

Loading ...
Support Center